WASHINGTON – Scott Gottlieb has been out of the U.S. FDA commissioner's seat for just over one month. Now, he is providing a few of his thoughts on reimbursement and the potential for Medicare for All, which he says has a "seductive political appeal for its seeming simplicity." This simplicity has prompted him to believe that "the prospects for single-payer Medicare are probably nearer to happen than I think many fully appreciate right now as a political matter." He made these comments during a presentation at the National Press Club in Washington, D.C., Friday. Read More
